An early lesion in hepatic carcinogenesis: Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region

Min Sun, James Eshleman, Linda D. Ferrell, Gretta Jacobs, Eulalia C. Sudilovsky, Ralph Tuthill, Mahmoud R. Hussein, Oscar Sudilovsky

Research output: Contribution to journalArticle

Abstract

Loss of heterozygosity (LOH) of chromosome 1 has been suggested, by karyotyping, to be an initial episode in human hepatocarcinogenesis. However, this alteration has not yet been investigated in cirrhotic nodules (CNs) or dysplastic nodules (DNs). In an initial study from explanted or resected cirrhotic livers, LOH in 1p36-p32 was examined in 31 hepatocellular carcinomas (HCCs), 25 low-grade dysplastic nodules (LGDNs), and 24 high-grade dysplastic nodules (HGDNs). In HCCs, LOH was detected most frequently at loci D1S2843 (1p36.1) (28.6%), D1S513 (1p34.3) (29.2%), and MYCL1 (1p34.1) (28.6%). In HGDN and LGDN, LOH incidences at D1S513 were 11.1% and 13.6%, respectively. To further refine those results and to determine sequential relationships among CN, DN, and HCC, LOH was next studied in an additional 53 HCCs, 56 HGDNs, 30 LGDNs, and 215 CNs from 11 explanted human cirrhotic livers, including 30 "nodule-in-nodule" lesions. Seven markers between D1S2843 (1p36.12) and MYCL1 (1p34.1), and 1 each at D1S484 (1q24.1), IGF2R-3 (6q26), and TP53 (17p13.1) were used. LOH at D1S2843 and D1S513 was detected in HCCs (20.4% and 23.5%, respectively), HGDNs (7.7% and 18.5%), LGDNs (13.6% and 6.9%), and CNs surrounding either HCCs or DNs (7.4% and 8.3%). These results demonstrate that LOH at D1S2843 and D1S513 are early events in human liver carcinogenesis. Data from CN surrounding either HCCs or DN, and also nodule-in-nodule lesions, provide evidence supporting a CN→DN→HCC progression. Different deletion patterns from multiple HCCs and DNs suggest independent origins for carcinogenesis in the same individual.

Original languageEnglish (US)
Pages (from-to)1415-1424
Number of pages10
JournalHepatology
Volume33
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Loss of Heterozygosity
Hepatocellular Carcinoma
Carcinogenesis
Liver
Karyotyping
Chromosomes, Human, Pair 1
Incidence

ASJC Scopus subject areas

  • Hepatology

Cite this

An early lesion in hepatic carcinogenesis : Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. / Sun, Min; Eshleman, James; Ferrell, Linda D.; Jacobs, Gretta; Sudilovsky, Eulalia C.; Tuthill, Ralph; Hussein, Mahmoud R.; Sudilovsky, Oscar.

In: Hepatology, Vol. 33, No. 6, 2001, p. 1415-1424.

Research output: Contribution to journalArticle

Sun, Min ; Eshleman, James ; Ferrell, Linda D. ; Jacobs, Gretta ; Sudilovsky, Eulalia C. ; Tuthill, Ralph ; Hussein, Mahmoud R. ; Sudilovsky, Oscar. / An early lesion in hepatic carcinogenesis : Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. In: Hepatology. 2001 ; Vol. 33, No. 6. pp. 1415-1424.
@article{afe95a9772d044b28f6e630beb3c3726,
title = "An early lesion in hepatic carcinogenesis: Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region",
abstract = "Loss of heterozygosity (LOH) of chromosome 1 has been suggested, by karyotyping, to be an initial episode in human hepatocarcinogenesis. However, this alteration has not yet been investigated in cirrhotic nodules (CNs) or dysplastic nodules (DNs). In an initial study from explanted or resected cirrhotic livers, LOH in 1p36-p32 was examined in 31 hepatocellular carcinomas (HCCs), 25 low-grade dysplastic nodules (LGDNs), and 24 high-grade dysplastic nodules (HGDNs). In HCCs, LOH was detected most frequently at loci D1S2843 (1p36.1) (28.6{\%}), D1S513 (1p34.3) (29.2{\%}), and MYCL1 (1p34.1) (28.6{\%}). In HGDN and LGDN, LOH incidences at D1S513 were 11.1{\%} and 13.6{\%}, respectively. To further refine those results and to determine sequential relationships among CN, DN, and HCC, LOH was next studied in an additional 53 HCCs, 56 HGDNs, 30 LGDNs, and 215 CNs from 11 explanted human cirrhotic livers, including 30 {"}nodule-in-nodule{"} lesions. Seven markers between D1S2843 (1p36.12) and MYCL1 (1p34.1), and 1 each at D1S484 (1q24.1), IGF2R-3 (6q26), and TP53 (17p13.1) were used. LOH at D1S2843 and D1S513 was detected in HCCs (20.4{\%} and 23.5{\%}, respectively), HGDNs (7.7{\%} and 18.5{\%}), LGDNs (13.6{\%} and 6.9{\%}), and CNs surrounding either HCCs or DNs (7.4{\%} and 8.3{\%}). These results demonstrate that LOH at D1S2843 and D1S513 are early events in human liver carcinogenesis. Data from CN surrounding either HCCs or DN, and also nodule-in-nodule lesions, provide evidence supporting a CN→DN→HCC progression. Different deletion patterns from multiple HCCs and DNs suggest independent origins for carcinogenesis in the same individual.",
author = "Min Sun and James Eshleman and Ferrell, {Linda D.} and Gretta Jacobs and Sudilovsky, {Eulalia C.} and Ralph Tuthill and Hussein, {Mahmoud R.} and Oscar Sudilovsky",
year = "2001",
doi = "10.1053/jhep.2001.24751",
language = "English (US)",
volume = "33",
pages = "1415--1424",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - An early lesion in hepatic carcinogenesis

T2 - Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region

AU - Sun, Min

AU - Eshleman, James

AU - Ferrell, Linda D.

AU - Jacobs, Gretta

AU - Sudilovsky, Eulalia C.

AU - Tuthill, Ralph

AU - Hussein, Mahmoud R.

AU - Sudilovsky, Oscar

PY - 2001

Y1 - 2001

N2 - Loss of heterozygosity (LOH) of chromosome 1 has been suggested, by karyotyping, to be an initial episode in human hepatocarcinogenesis. However, this alteration has not yet been investigated in cirrhotic nodules (CNs) or dysplastic nodules (DNs). In an initial study from explanted or resected cirrhotic livers, LOH in 1p36-p32 was examined in 31 hepatocellular carcinomas (HCCs), 25 low-grade dysplastic nodules (LGDNs), and 24 high-grade dysplastic nodules (HGDNs). In HCCs, LOH was detected most frequently at loci D1S2843 (1p36.1) (28.6%), D1S513 (1p34.3) (29.2%), and MYCL1 (1p34.1) (28.6%). In HGDN and LGDN, LOH incidences at D1S513 were 11.1% and 13.6%, respectively. To further refine those results and to determine sequential relationships among CN, DN, and HCC, LOH was next studied in an additional 53 HCCs, 56 HGDNs, 30 LGDNs, and 215 CNs from 11 explanted human cirrhotic livers, including 30 "nodule-in-nodule" lesions. Seven markers between D1S2843 (1p36.12) and MYCL1 (1p34.1), and 1 each at D1S484 (1q24.1), IGF2R-3 (6q26), and TP53 (17p13.1) were used. LOH at D1S2843 and D1S513 was detected in HCCs (20.4% and 23.5%, respectively), HGDNs (7.7% and 18.5%), LGDNs (13.6% and 6.9%), and CNs surrounding either HCCs or DNs (7.4% and 8.3%). These results demonstrate that LOH at D1S2843 and D1S513 are early events in human liver carcinogenesis. Data from CN surrounding either HCCs or DN, and also nodule-in-nodule lesions, provide evidence supporting a CN→DN→HCC progression. Different deletion patterns from multiple HCCs and DNs suggest independent origins for carcinogenesis in the same individual.

AB - Loss of heterozygosity (LOH) of chromosome 1 has been suggested, by karyotyping, to be an initial episode in human hepatocarcinogenesis. However, this alteration has not yet been investigated in cirrhotic nodules (CNs) or dysplastic nodules (DNs). In an initial study from explanted or resected cirrhotic livers, LOH in 1p36-p32 was examined in 31 hepatocellular carcinomas (HCCs), 25 low-grade dysplastic nodules (LGDNs), and 24 high-grade dysplastic nodules (HGDNs). In HCCs, LOH was detected most frequently at loci D1S2843 (1p36.1) (28.6%), D1S513 (1p34.3) (29.2%), and MYCL1 (1p34.1) (28.6%). In HGDN and LGDN, LOH incidences at D1S513 were 11.1% and 13.6%, respectively. To further refine those results and to determine sequential relationships among CN, DN, and HCC, LOH was next studied in an additional 53 HCCs, 56 HGDNs, 30 LGDNs, and 215 CNs from 11 explanted human cirrhotic livers, including 30 "nodule-in-nodule" lesions. Seven markers between D1S2843 (1p36.12) and MYCL1 (1p34.1), and 1 each at D1S484 (1q24.1), IGF2R-3 (6q26), and TP53 (17p13.1) were used. LOH at D1S2843 and D1S513 was detected in HCCs (20.4% and 23.5%, respectively), HGDNs (7.7% and 18.5%), LGDNs (13.6% and 6.9%), and CNs surrounding either HCCs or DNs (7.4% and 8.3%). These results demonstrate that LOH at D1S2843 and D1S513 are early events in human liver carcinogenesis. Data from CN surrounding either HCCs or DN, and also nodule-in-nodule lesions, provide evidence supporting a CN→DN→HCC progression. Different deletion patterns from multiple HCCs and DNs suggest independent origins for carcinogenesis in the same individual.

UR - http://www.scopus.com/inward/record.url?scp=0034991865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034991865&partnerID=8YFLogxK

U2 - 10.1053/jhep.2001.24751

DO - 10.1053/jhep.2001.24751

M3 - Article

C2 - 11391530

AN - SCOPUS:0034991865

VL - 33

SP - 1415

EP - 1424

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -